0001209191-22-005923.txt : 20220201
0001209191-22-005923.hdr.sgml : 20220201
20220201163641
ACCESSION NUMBER: 0001209191-22-005923
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220128
FILED AS OF DATE: 20220201
DATE AS OF CHANGE: 20220201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pinto Shelly
CENTRAL INDEX KEY: 0001857740
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39386
FILM NUMBER: 22579412
MAIL ADDRESS:
STREET 1: 866 MALCOLM ROAD, SUITE 100
CITY: BURLINGAME
STATE: CA
ZIP: 94010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALX ONCOLOGY HOLDINGS INC
CENTRAL INDEX KEY: 0001810182
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 850642577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 323 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-466-7125
MAIL ADDRESS:
STREET 1: 323 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-28
0
0001810182
ALX ONCOLOGY HOLDINGS INC
ALXO
0001857740
Pinto Shelly
C/O ALX ONCOLOGY HOLDINGS INC.
323 ALLERTON AVENUE
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
VP, Finance and CAO
Common Stock
2022-01-28
4
A
0
50000
0.00
A
50446
D
The reported shares are represented by restricted stock units, or RSUs, which vest as follows: three-eighths of the RSUs vest on July 3, 2023 and the remaining RSUs vest thereafter in five equal semiannual installments.
Includes 446 shares acquired under the Issuer's employee stock purchase plan on December 31, 2021.
/s/ Peter Garcia, by power of attorney
2022-02-01